Overview of CRISPR
CRISPR is an innovative instrument that is reshaping lives and creating significant impact in the healthcare sector. CRISPR, an acronym for “Clustered Regularly Interspaced Short Palindromic Repeats,” exists in prokaryotes—tiny, unicellular organisms that lack organelles. These sequences are found within the genomes of prokaryotes, which organize a cell’s DNA into clusters.
Serving as a gene-editing mechanism, CRISPR facilitates modifications to targeted DNA segments to combat serious diseases. It is particularly valuable as it aids the body’s defense against viral threats by integrating the foreign DNA into its own genome, allowing for recognition and elimination of the virus in subsequent encounters. What stands out is that, in comparison with other gene editing techniques, CRISPR is much more accurate and simpler to configure, streamlining the sequence alteration process. While many conventional gene-editing methods utilize a single protein, CRISPR employs RNA-guided targeting together with the Cas9 enzyme.
Mechanism of CRISPR
CRISPR operates by leveraging a natural defense system in bacteria that enables them to detect and eliminate viral attackers. When a virus infiltrates a bacterial cell (a prokaryote), the bacterium retains a fragment of the invader’s DNA in its own genome as a genetic “memory.” This grants the bacterium the ability to identify and respond more adeptly to future invasions.
In gene editing, this mechanism is adapted with two essential components: the Cas9 enzyme, which acts akin to molecular scissors to cleave DNA, and guide RNA, which directs Cas9 to the specific DNA sequence requiring modification. Once the designated DNA is severed, the cell’s inherent repair processes engage, allowing researchers to implement alterations to the genetic material.
In contrast to earlier tools that depended on difficult-to-reprogram proteins, CRISPR’s RNA-guided framework is more adaptable, simpler to construct, and exceptionally accurate. This ease and precision have permitted CRISPR to be utilized in medicine, agriculture, manufacturing, and microbiology—such as altering microbes to boost yield. However, as this article discusses, burgeoning capabilities bring with them escalating ethical dilemmas, especially concerning germline editing and genetic enhancement.
First Individual to Undergo Personalized CRISPR Therapy
In February 2025, the inaugural personalized CRISPR therapy was carried out for an infant named KJ to address a deficiency in Carbamoyl Phosphate Synthetase 1 (CPS1)—an enzyme essential for converting ammonia (produced during protein metabolism) into urea. A team headed by Dr. Rebecca Ahrens-Nicklas and Dr. Kiran Musunuru at the Children’s Hospital of Philadelphia formulated this treatment following extensive research in gene editing and collaboration with other healthcare professionals.
Their efforts concentrated on conditions impacting the urea cycle, which results in harmful ammonia accumulation, leading to damage in vital organs like the brain and liver. They customized the treatment specifically for KJ’s variant of CPS1 deficiency utilizing preclinical findings on analogous alterations.
Up until this point, the only CRISPR treatments sanctioned by the U.S. FDA have targeted more prevalent conditions such as sickle cell disease and beta thalassemia, which impact tens of thousands to hundreds of thousands of patients. In KJ’s scenario, his treatment was developed within six months of his birth, focusing on his unique CPS1 variant. The team created a base editing therapy administered via lipid nanoparticles to his liver to rectify the dysfunctional enzyme.
The treatment in February was the initial of three doses; KJ received the subsequent two in March and April 2025. As of his final administration, he has not experienced any serious adverse effects, demonstrates enhanced tolerance to dietary protein, and requires reduced medication to regulate ammonia levels. Although he will necessitate continual monitoring, Ahrens-Nicklas states that the outcomes thus far are encouraging.
Ethical Implications of CRISPR
Like any pioneering technology, CRIS…